Explore patient considerations
when determining frontline treatment with Dr. Kenneth Shain, Director of the Myeloma Working Group at Moffitt Cancer Center.
View Transcript
Watch KOL expert series
on continuous frontline treatment with DARZALEX® (daratumumab) + Rd and patient outcomes with Dr. Suzanne Reim Fanning, Associate Professor at USC School of Medicine Greenville.
View Transcript